DD260495A5 - Verfahren zur herstellung neuer substituierter benzamide - Google Patents

Verfahren zur herstellung neuer substituierter benzamide Download PDF

Info

Publication number
DD260495A5
DD260495A5 DD86297795A DD29779586A DD260495A5 DD 260495 A5 DD260495 A5 DD 260495A5 DD 86297795 A DD86297795 A DD 86297795A DD 29779586 A DD29779586 A DD 29779586A DD 260495 A5 DD260495 A5 DD 260495A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
amino
methoxy
dihydro
temperature
Prior art date
Application number
DD86297795A
Other languages
German (de)
English (en)
Inventor
Mr Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Original Assignee
�������@�}������@�������������@��@�������������@��@�}���@��`������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@�}������@�������������@��@�������������@��@�}���@��`������k�� filed Critical �������@�}������@�������������@��@�������������@��@�}���@��`������k��
Publication of DD260495A5 publication Critical patent/DD260495A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DD86297795A 1985-12-19 1986-12-17 Verfahren zur herstellung neuer substituierter benzamide DD260495A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518829A FR2592042B1 (fr) 1985-12-19 1985-12-19 Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
DD260495A5 true DD260495A5 (de) 1988-09-28

Family

ID=9325965

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86297795A DD260495A5 (de) 1985-12-19 1986-12-17 Verfahren zur herstellung neuer substituierter benzamide

Country Status (37)

Country Link
US (2) US4835172A (xx)
EP (1) EP0236646B1 (xx)
JP (1) JPS62246553A (xx)
KR (1) KR930004653B1 (xx)
CN (1) CN1018454B (xx)
AR (1) AR242193A1 (xx)
AT (1) ATE57376T1 (xx)
AU (1) AU586057B2 (xx)
CA (2) CA1298301C (xx)
CH (1) CH671396A5 (xx)
CS (1) CS274285B2 (xx)
DD (1) DD260495A5 (xx)
DE (2) DE3674916D1 (xx)
DK (1) DK612886A (xx)
ES (1) ES2036178T3 (xx)
FI (1) FI865190A (xx)
FR (1) FR2592042B1 (xx)
GB (1) GB2184723B (xx)
GR (1) GR3002524T3 (xx)
HU (1) HU196794B (xx)
IE (1) IE59212B1 (xx)
IL (1) IL81010A (xx)
IN (1) IN163130B (xx)
IS (1) IS1448B6 (xx)
MA (1) MA20835A1 (xx)
NO (1) NO168176C (xx)
NZ (1) NZ218675A (xx)
OA (1) OA08564A (xx)
PH (2) PH24365A (xx)
PL (1) PL148408B1 (xx)
PT (1) PT83982B (xx)
SU (1) SU1496632A3 (xx)
TN (1) TNSN86165A1 (xx)
YU (1) YU44796B (xx)
ZA (1) ZA869560B (xx)
ZM (1) ZM10686A1 (xx)
ZW (1) ZW24886A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295350B1 (fr) * 1987-06-17 1992-11-11 Laboratoires DELAGRANGE Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US20050140688A1 (en) * 2003-12-29 2005-06-30 Kim Pallister Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR1539104A (fr) * 1967-07-31 1968-09-13 Ile De France Nouveaux benzamides et leur procédé de préparation
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
DE1963193A1 (de) * 1969-12-17 1971-06-24 Bayer Ag N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2905883A1 (de) * 1979-02-16 1980-08-28 Boehringer Sohn Ingelheim Radioimmuntest fuer clonidin
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
US4461904A (en) * 1981-11-20 1984-07-24 Alcon Laboratories, Inc. 2-(Trisubstituted phenylimino)-imidazolines
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6341471A (ja) * 1986-08-08 1988-02-22 Nippon Soda Co Ltd オキサ(チア)ゾリジン誘導体、その製造法及び殺ダニ剤
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

Also Published As

Publication number Publication date
DK612886A (da) 1987-06-20
OA08564A (fr) 1988-09-30
TNSN86165A1 (fr) 1990-01-01
NO865148L (no) 1987-06-22
CH671396A5 (xx) 1989-08-31
DE3674916D1 (de) 1990-11-15
GB8630143D0 (en) 1987-01-28
HUT43844A (en) 1987-12-28
CA1298301C (fr) 1992-03-31
IL81010A (en) 1991-06-30
YU217986A (en) 1987-12-31
GR3002524T3 (en) 1993-01-25
FR2592042A1 (fr) 1987-06-26
NO168176C (no) 1992-01-22
ZM10686A1 (en) 1987-11-27
EP0236646A1 (fr) 1987-09-16
AU586057B2 (en) 1989-06-29
CS960386A2 (en) 1990-09-12
PH24469A (en) 1990-07-18
PT83982B (pt) 1989-01-17
FI865190A0 (fi) 1986-12-18
PH24365A (en) 1990-06-13
KR930004653B1 (ko) 1993-06-02
PL263078A1 (en) 1988-04-14
HU196794B (en) 1989-01-30
NO865148D0 (no) 1986-12-18
AR242193A1 (es) 1993-03-31
US4914117A (en) 1990-04-03
IS1448B6 (is) 1991-01-16
DK612886D0 (da) 1986-12-18
ES2036178T3 (es) 1993-05-16
IS3178A7 (is) 1987-06-20
JPS62246553A (ja) 1987-10-27
AU6668786A (en) 1987-06-25
KR870006008A (ko) 1987-07-08
CS274285B2 (en) 1991-04-11
IN163130B (xx) 1988-08-13
SU1496632A3 (ru) 1989-07-23
GB2184723A (en) 1987-07-01
YU44796B (en) 1991-02-28
CN1018454B (zh) 1992-09-30
NZ218675A (en) 1990-06-26
MA20835A1 (fr) 1987-07-01
EP0236646B1 (fr) 1990-10-10
IE59212B1 (en) 1994-01-26
PL148408B1 (en) 1989-10-31
FR2592042B1 (fr) 1988-03-25
NO168176B (no) 1991-10-14
CA1299579C (fr) 1992-04-28
ZA869560B (en) 1987-11-25
US4835172A (en) 1989-05-30
CN86108972A (zh) 1987-11-18
DE3643103A1 (de) 1987-06-25
IL81010A0 (en) 1987-03-31
GB2184723B (en) 1989-12-28
FI865190A (fi) 1987-06-20
IE863270L (en) 1987-06-19
ATE57376T1 (de) 1990-10-15
PT83982A (en) 1987-01-01
ZW24886A1 (en) 1987-05-13

Similar Documents

Publication Publication Date Title
DE1595915C3 (de) Pyrrolidinderivate
DE1770153C3 (de) Heterocyclische Aminoketone, deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu ihrer Herstellung
EP0276803B1 (de) 1-(4-Hydroxy-3,5-di-tert.-butyl-benzoyl)-homopiperazin, verschiedene von dessen Derivaten, Verfahren zur Herstellung dieser Verbindungen, die sie enthaltenden Arzneimittel und ihre Verwendung
CH641159A5 (de) Verfahren zur herstellung von neuen guanidinderivaten.
DE2316920B2 (de) Benzo eckige klammer auf d eckige klammer zu eckige klammer auf 1,3 eckige klammer zu dioxolderivate, deren herstellung und diese enthaltende arzneimittel
DE2704989A1 (de) Arzneimittel, in diesen enthaltene neue verbindungen und verfahren zu ihrer herstellung
DE2727047A1 (de) Indol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DD260495A5 (de) Verfahren zur herstellung neuer substituierter benzamide
DE2235935C3 (de) Neue Derivate von trijodierten Aminobenzolcarbonsäuren, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Röntgenkontrastmittel
DE1618465C3 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2157272C3 (de) Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff
DE1470205B1 (de) 5-Nitropyrrolderivate und Verfahren zu ihrer Herstellung
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2810143A1 (de) Aryl-alpha, alpha-bis eckige klammer auf omega- (disubstituierte amino) alkyl eckige klammer zu acetamide und deren saeureanlagerungssalze, verfahren zu ihrer herstellung sowie sie enthaltende arzneimittelzubereitungen
DE2944293A1 (de) Alpha , alpha , alpha -trifluor- (aminoaryl)-aethanole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3004348C2 (xx)
DE2144641C3 (de) Phenylacethydroxamsäuren und Verfahren zu ihrer Herstellung
DE2354931C2 (de) trans-2-Phenylbicyclooctan-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DD258812A1 (de) Verfahren zur herstellung neuer ixoxazolderivate
DE2507429A1 (de) Aminosaeureester, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2512702C2 (de) Substituierte 1-Amino-3-phenyl-indole, deren Salze und Verfahren zu ihrer Herstellung
DE2540334C2 (de) Benzylaminoalkansäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2012667C3 (de) 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate
DE2711149B2 (xx)
DD150060A5 (de) Verfahren zur herstellung von neuen phenthiazin-derivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee